1. Service Overview & Global Regulatory Compliance Framework
Our process-centric facility design delivers biomanufacturing-oriented, compliance-embedded infrastructure solutions tailored for biopharmaceutical production, fully compliant with FDA cGMP, EMA Annex 1, PIC/S harmonized GMP and ICH Q8/Q9/Q10 quality-by-design and risk-based quality management standards. Differentiated from conventional architecture-driven design, our services take bioprocess workflow and production logic as the core design benchmark, covering master plant layout, cleanroom zoning, sanitary fluid path planning, MEP utility configuration and compliance design documentation. We fully support the industrialization of monoclonal antibodies, recombinant proteins, viral vectors and vaccines, catering to greenfield plant construction, brownfield process upgrading and multi-product flexible manufacturing base renovation. Traditional facility design often causes prevalent industry pain points including process-facility mismatch, unreasonable personnel/material flow crossover, redundant sanitary dead spaces, mismatched utility load capacity and insufficient process validation compatibility. We eliminate structural engineering defects through front-loaded process-oriented design logic, providing audit-ready, production-optimized facility solutions for global biotech enterprises and professional CMO manufacturing platforms.
2. Core Design Philosophy & Process-Driven Technical Advantages
Guided by intrinsic process determinism and preemptive compliance embedding, our process-centric design prioritizes bioprocess reproducibility and batch quality stability over conventional spatial aesthetics and structural simplicity. All cleanroom classification, HVAC pressure cascade, unidirectional flow organization, ASME BPE sanitary piping routing and equipment positioning are scientifically customized based on product critical quality attributes (CQAs) and critical process parameters (CPPs). We deeply integrate upstream cell culture, downstream purification and sterile formulation process characteristics into facility engineering, realizing minimal open operation exposure, effective cross-contamination segregation and optimal mass transfer and fluid transmission efficiency. Unlike generic architectural design that leads to post-construction process adaptation and costly modification, our model achieves one-step process-facility matching, simplifies subsequent CQV qualification procedures, reduces long-term operational deviation risks and maintains continuous GMP inspection readiness for biomanufacturing facilities.
3. Four Core Process-Centric Design Modules & Standard Deliverables
Our complete process-centric biopharmaceutical facility design system consists of four interlocked full-process functional modules covering process planning to compliant engineering delivery: process-matched master planning module, workflow-driven sanitary layout module, process utility optimization module, and GMP compliance design documentation module. The master planning module conducts process route demonstration, production capacity matching analysis, functional zoning partitioning and BIM 3D spatial optimization, delivering process-aligned URS and DQ design documents. The sanitary layout module optimizes end-to-end biomanufacturing workflow, establishes independent personnel and material circulation paths, and configures classified aseptic operation zones to adapt to full-process closed and semi-closed production requirements. The utility optimization module designs targeted HVAC clean air systems, WFI/PW distribution networks, CIP/SIP circulation loops and process automation interfaces to fully match process parameter windows and operational frequency. The compliance documentation module compiles process FMEA risk assessment, contamination control strategy, design gap analysis and full English-version engineering dossiers to support regulatory audit and process validation. Standard deliverables include complete process design drawings, technical specifications and validation supporting archives.
4. Industrial Application & Full Lifecycle Design Support
Our process-centric facility design solutions are widely applied in commercial biomanufacturing campuses, clinical pilot process platforms, high-standard sterile biologic production lines and flexible multi-product CMO facilities. Adopting modular and process-scalable architecture, all design schemes reserve flexible expansion and process iteration interfaces, supporting future process intensification transformation, capacity expansion and new product pipeline switching without large-scale facility reconstruction. We provide full-lifecycle technical support including design technical disclosure, on-site process adaptation verification, as-built drawing confirmation, FAT/SAT process matching guidance and long-term regulatory standard update consultation. By realizing deep integration of bioprocess logic and facility engineering, our design helps global biopharmaceutical clients build highly efficient, low-deviation and fully audit-ready manufacturing infrastructure, stabilize batch-to-batch product consistency and accelerate the global commercialization of innovative biotherapeutics.
